Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Assets Average (2020 - 2025)

Immunocore Holdings (IMCR) has disclosed Assets Average for 5 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 3.61% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 3.61% year-over-year, with the annual reading at $1.0 billion for FY2025, 29.27% up from the prior year.
  • Assets Average hit $1.1 billion in Q4 2025 for Immunocore Holdings, down from $1.1 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.1 billion in Q3 2025 to a low of $333.6 million in Q4 2021.
  • Historically, Assets Average has averaged $894.9 million across 4 years, with a median of $1.0 billion in 2024.
  • Biggest five-year swings in Assets Average: skyrocketed 37.54% in 2022 and later rose 3.61% in 2025.
  • Year by year, Assets Average stood at $333.6 million in 2021, then surged by 37.54% to $458.8 million in 2022, then surged by 128.21% to $1.0 billion in 2024, then increased by 3.61% to $1.1 billion in 2025.
  • Business Quant data shows Assets Average for IMCR at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.